Junior scientist Dr Lika Drakhlis receives the research prize of the Dresden Cardiovascular Days 2025.

MHH project LuFex aims to develop a new inhalative treatment with a plant-based anti-fibrosis drug and is receiving 800,000 euros from the biomedical…

„Sounds“: MHH und AOK Niedersachsen starten Forschungsprojekt mit rund einer Million Euro Fördergeld.

Participants sought for online survey: study is investigating the experiences of people who care for seriously ill people in their neighbourhood,…

MHH researchers publish two new studies on treatment with bromocriptine and on the possibility of a subsequent pregnancy in women with PPCM.

MHH project RELIEV develops digital therapy platform for better medical care of people with inflammatory rheumatic diseases.

From Molecule to Human Health: MHH launches pioneering diagnostic and therapeutic approaches at molecular and cellular level.

MHH Dean of Academic Career Development advocates targeted further development of structured support programmes for researching doctors.

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is…

MHH research team disables tumour cells with synthetic Adhibin and prevents migration and attachment to other cells.